26 March 2020

Since the outbreak of COVID-19, we have had to accept that we will simply not be able to manage patients with colorectal disease as normal. A particular concern is how best to manage the many patients diagnosed and living with bowel cancer during the evolving crisis as the UK and Ireland try to mitigate the impact of COVID- 19 and save patient lives. Previously unimaginable pressures on our services and resources have moved us to a “wartime” footing and will heavily impede delivery of normal standards of colorectal cancer care in either surgery or oncology.

ACPGBI Statement on CRC treatment during COVID-19

View other News